-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Editas Medicine, Inc. quarterly/annual Depreciation history and growth rate from 2014 to Q1 2025.
- Editas Medicine, Inc. Depreciation for the quarter ending March 31, 2025 was $1.92M, a 36.1% increase year-over-year.
- Editas Medicine, Inc. annual Depreciation for 2024 was $5.81M, a 4.21% decline from 2023.
- Editas Medicine, Inc. annual Depreciation for 2023 was $6.06M, a 4.31% decline from 2022.
- Editas Medicine, Inc. annual Depreciation for 2022 was $6.34M, a 25.4% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)